In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Cook County jury rules heartburn medication Zantac not responsible for plaintiff's cancer; Pfizer settles over 10,000 ...
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn ...
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer ...
Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from ...
A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her ...
In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez ...
A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This ...
A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.
Sen. Ron Wyden questions why Pfizer's tax rate over the last few years is significantly less than the U.S. corporate tax rate ...
Big drugmakers already face some 80,000 state suits from users of the drug who say their cancers were caused by Zantac ...